
    
      OBJECTIVES:

      Primary

        -  To determine a prognostic scale of the feasibility of chemotherapy (at least two-thirds
           of the dose intensity usually administered) in patients aged 75 years or older with
           solid tumour.

      Secondary

        -  To evaluate the efficacy, in terms of clinical and/or biological response, of treatments
           administered.

        -  To evaluate the incidence of severe (grade 3-4) toxicity.

      OUTLINE: This is a multicenter study. Patients receive one of the following regimens
      according to cancer diagnosis and principal investigator preference. All regimens last 3
      months.
    
  